Click for best price
Phase I IV Clinical Development Services Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Phase I - IV Clinical Development Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phase I - IV Clinical Development Services. This report contains market size and forecasts of Phase I - IV Clinical Development Services in global, including the following market information:
Global Phase I - IV Clinical Development Services Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Phase I - IV Clinical Development Services market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Early Phase Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Phase I - IV Clinical Development Services include Syneos Health, PPD, GVI CDS, Parexel, Clinical Leader, Thermo Fisher Scientific, LabCorp, Worldwide Clinical Trial and CROS NT, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Phase I - IV Clinical Development Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Phase I - IV Clinical Development Services Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Phase I - IV Clinical Development Services Market Segment Percentages, by Type, 2022 (%)
Early Phase
Phase II-III
Phase IIIb-IV
Global Phase I - IV Clinical Development Services Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Phase I - IV Clinical Development Services Market Segment Percentages, by Application, 2022 (%)
Pharmaceutical Companies
Medical Device Companies
Contract Research Organizations
Global Phase I - IV Clinical Development Services Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Phase I - IV Clinical Development Services Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Phase I - IV Clinical Development Services revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Phase I - IV Clinical Development Services revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Syneos Health
PPD
GVI CDS
Parexel
Clinical Leader
Thermo Fisher Scientific
LabCorp
Worldwide Clinical Trial
CROS NT
Dynakin
Rho, Inc.
Synteract
ICBio CRO
Sofpromed
Profil
ICON Plc
Clinipace
OCT Clinical
EPS Group
Beijing Sun-novo Pharmaceutical Research
Dmedglobal
WuXi AppTec
Elixir Clinical Research
Outline of Major Chapters:
Chapter 1: Introduces the definition of Phase I - IV Clinical Development Services, market overview.
Chapter 2: Global Phase I - IV Clinical Development Services market size in revenue.
Chapter 3: Detailed analysis of Phase I - IV Clinical Development Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Phase I - IV Clinical Development Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Phase I - IV Clinical Development Services Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
110 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Phase I - IV Clinical Development Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Phase I - IV Clinical Development Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Phase I - IV Clinical Development Services Overall Market Size
2.1 Global Phase I - IV Clinical Development Services Market Size: 2022 VS 2029
2.2 Global Phase I - IV Clinical Development Services Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Phase I - IV Clinical Development Services Players in Global Market
3.2 Top Global Phase I - IV Clinical Development Services Companies Ranked by Revenue
3.3 Global Phase I - IV Clinical Development Services Revenue by Companies
3.4 Top 3 and Top 5 Phase I - IV Clinical Development Services Companies in Global Market, by Revenue in 2022
3.5 Global Companies Phase I - IV Clinical Development Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Phase I - IV Clinical Development Services Players in Global Market
3.6.1 List of Global Tier 1 Phase I - IV Clinical Development Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Phase I - IV Clinical Development Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Phase I - IV Clinical Development Services Market Size Markets, 2022 & 2029
4.1.2 Early Phase
4.1.3 Phase II-III
4.1.4 Phase IIIb-IV
4.2 By Type - Global Phase I - IV Clinical Development Services Revenue & Forecasts
4.2.1 By Type - Global Phase I - IV Clinical Development Services Revenue, 2018-2023
4.2.2 By Type - Global Phase I - IV Clinical Development Services Revenue, 2024-2029
4.2.3 By Type - Global Phase I - IV Clinical Development Services Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Phase I - IV Clinical Development Services Market Size, 2022 & 2029
5.1.2 Pharmaceutical Companies
5.1.3 Medical Device Companies
5.1.4 Contract Research Organizations
5.2 By Application - Global Phase I - IV Clinical Development Services Revenue & Forecasts
5.2.1 By Application - Global Phase I - IV Clinical Development Services Revenue, 2018-2023
5.2.2 By Application - Global Phase I - IV Clinical Development Services Revenue, 2024-2029
5.2.3 By Application - Global Phase I - IV Clinical Development Services Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Phase I - IV Clinical Development Services Market Size, 2022 & 2029
6.2 By Region - Global Phase I - IV Clinical Development Services Revenue & Forecasts
6.2.1 By Region - Global Phase I - IV Clinical Development Services Revenue, 2018-2023
6.2.2 By Region - Global Phase I - IV Clinical Development Services Revenue, 2024-2029
6.2.3 By Region - Global Phase I - IV Clinical Development Services Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Phase I - IV Clinical Development Services Revenue, 2018-2029
6.3.2 US Phase I - IV Clinical Development Services Market Size, 2018-2029
6.3.3 Canada Phase I - IV Clinical Development Services Market Size, 2018-2029
6.3.4 Mexico Phase I - IV Clinical Development Services Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Phase I - IV Clinical Development Services Revenue, 2018-2029
6.4.2 Germany Phase I - IV Clinical Development Services Market Size, 2018-2029
6.4.3 France Phase I - IV Clinical Development Services Market Size, 2018-2029
6.4.4 U.K. Phase I - IV Clinical Development Services Market Size, 2018-2029
6.4.5 Italy Phase I - IV Clinical Development Services Market Size, 2018-2029
6.4.6 Russia Phase I - IV Clinical Development Services Market Size, 2018-2029
6.4.7 Nordic Countries Phase I - IV Clinical Development Services Market Size, 2018-2029
6.4.8 Benelux Phase I - IV Clinical Development Services Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Phase I - IV Clinical Development Services Revenue, 2018-2029
6.5.2 China Phase I - IV Clinical Development Services Market Size, 2018-2029
6.5.3 Japan Phase I - IV Clinical Development Services Market Size, 2018-2029
6.5.4 South Korea Phase I - IV Clinical Development Services Market Size, 2018-2029
6.5.5 Southeast Asia Phase I - IV Clinical Development Services Market Size, 2018-2029
6.5.6 India Phase I - IV Clinical Development Services Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Phase I - IV Clinical Development Services Revenue, 2018-2029
6.6.2 Brazil Phase I - IV Clinical Development Services Market Size, 2018-2029
6.6.3 Argentina Phase I - IV Clinical Development Services Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Phase I - IV Clinical Development Services Revenue, 2018-2029
6.7.2 Turkey Phase I - IV Clinical Development Services Market Size, 2018-2029
6.7.3 Israel Phase I - IV Clinical Development Services Market Size, 2018-2029
6.7.4 Saudi Arabia Phase I - IV Clinical Development Services Market Size, 2018-2029
6.7.5 UAE Phase I - IV Clinical Development Services Market Size, 2018-2029
7 Phase I - IV Clinical Development Services Companies Profiles
7.1 Syneos Health
7.1.1 Syneos Health Company Summary
7.1.2 Syneos Health Business Overview
7.1.3 Syneos Health Phase I - IV Clinical Development Services Major Product Offerings
7.1.4 Syneos Health Phase I - IV Clinical Development Services Revenue in Global Market (2018-2023)
7.1.5 Syneos Health Key News & Latest Developments
7.2 PPD
7.2.1 PPD Company Summary
7.2.2 PPD Business Overview
7.2.3 PPD Phase I - IV Clinical Development Services Major Product Offerings
7.2.4 PPD Phase I - IV Clinical Development Services Revenue in Global Market (2018-2023)
7.2.5 PPD Key News & Latest Developments
7.3 GVI CDS
7.3.1 GVI CDS Company Summary
7.3.2 GVI CDS Business Overview
7.3.3 GVI CDS Phase I - IV Clinical Development Services Major Product Offerings
7.3.4 GVI CDS Phase I - IV Clinical Development Services Revenue in Global Market (2018-2023)
7.3.5 GVI CDS Key News & Latest Developments
7.4 Parexel
7.4.1 Parexel Company Summary
7.4.2 Parexel Business Overview
7.4.3 Parexel Phase I - IV Clinical Development Services Major Product Offerings
7.4.4 Parexel Phase I - IV Clinical Development Services Revenue in Global Market (2018-2023)
7.4.5 Parexel Key News & Latest Developments
7.5 Clinical Leader
7.5.1 Clinical Leader Company Summary
7.5.2 Clinical Leader Business Overview
7.5.3 Clinical Leader Phase I - IV Clinical Development Services Major Product Offerings
7.5.4 Clinical Leader Phase I - IV Clinical Development Services Revenue in Global Market (2018-2023)
7.5.5 Clinical Leader Key News & Latest Developments
7.6 Thermo Fisher Scientific
7.6.1 Thermo Fisher Scientific Company Summary
7.6.2 Thermo Fisher Scientific Business Overview
7.6.3 Thermo Fisher Scientific Phase I - IV Clinical Development Services Major Product Offerings
7.6.4 Thermo Fisher Scientific Phase I - IV Clinical Development Services Revenue in Global Market (2018-2023)
7.6.5 Thermo Fisher Scientific Key News & Latest Developments
7.7 LabCorp
7.7.1 LabCorp Company Summary
7.7.2 LabCorp Business Overview
7.7.3 LabCorp Phase I - IV Clinical Development Services Major Product Offerings
7.7.4 LabCorp Phase I - IV Clinical Development Services Revenue in Global Market (2018-2023)
7.7.5 LabCorp Key News & Latest Developments
7.8 Worldwide Clinical Trial
7.8.1 Worldwide Clinical Trial Company Summary
7.8.2 Worldwide Clinical Trial Business Overview
7.8.3 Worldwide Clinical Trial Phase I - IV Clinical Development Services Major Product Offerings
7.8.4 Worldwide Clinical Trial Phase I - IV Clinical Development Services Revenue in Global Market (2018-2023)
7.8.5 Worldwide Clinical Trial Key News & Latest Developments
7.9 CROS NT
7.9.1 CROS NT Company Summary
7.9.2 CROS NT Business Overview
7.9.3 CROS NT Phase I - IV Clinical Development Services Major Product Offerings
7.9.4 CROS NT Phase I - IV Clinical Development Services Revenue in Global Market (2018-2023)
7.9.5 CROS NT Key News & Latest Developments
7.10 Dynakin
7.10.1 Dynakin Company Summary
7.10.2 Dynakin Business Overview
7.10.3 Dynakin Phase I - IV Clinical Development Services Major Product Offerings
7.10.4 Dynakin Phase I - IV Clinical Development Services Revenue in Global Market (2018-2023)
7.10.5 Dynakin Key News & Latest Developments
7.11 Rho, Inc.
7.11.1 Rho, Inc. Company Summary
7.11.2 Rho, Inc. Business Overview
7.11.3 Rho, Inc. Phase I - IV Clinical Development Services Major Product Offerings
7.11.4 Rho, Inc. Phase I - IV Clinical Development Services Revenue in Global Market (2018-2023)
7.11.5 Rho, Inc. Key News & Latest Developments
7.12 Synteract
7.12.1 Synteract Company Summary
7.12.2 Synteract Business Overview
7.12.3 Synteract Phase I - IV Clinical Development Services Major Product Offerings
7.12.4 Synteract Phase I - IV Clinical Development Services Revenue in Global Market (2018-2023)
7.12.5 Synteract Key News & Latest Developments
7.13 ICBio CRO
7.13.1 ICBio CRO Company Summary
7.13.2 ICBio CRO Business Overview
7.13.3 ICBio CRO Phase I - IV Clinical Development Services Major Product Offerings
7.13.4 ICBio CRO Phase I - IV Clinical Development Services Revenue in Global Market (2018-2023)
7.13.5 ICBio CRO Key News & Latest Developments
7.14 Sofpromed
7.14.1 Sofpromed Company Summary
7.14.2 Sofpromed Business Overview
7.14.3 Sofpromed Phase I - IV Clinical Development Services Major Product Offerings
7.14.4 Sofpromed Phase I - IV Clinical Development Services Revenue in Global Market (2018-2023)
7.14.5 Sofpromed Key News & Latest Developments
7.15 Profil
7.15.1 Profil Company Summary
7.15.2 Profil Business Overview
7.15.3 Profil Phase I - IV Clinical Development Services Major Product Offerings
7.15.4 Profil Phase I - IV Clinical Development Services Revenue in Global Market (2018-2023)
7.15.5 Profil Key News & Latest Developments
7.16 ICON Plc
7.16.1 ICON Plc Company Summary
7.16.2 ICON Plc Business Overview
7.16.3 ICON Plc Phase I - IV Clinical Development Services Major Product Offerings
7.16.4 ICON Plc Phase I - IV Clinical Development Services Revenue in Global Market (2018-2023)
7.16.5 ICON Plc Key News & Latest Developments
7.17 Clinipace
7.17.1 Clinipace Company Summary
7.17.2 Clinipace Business Overview
7.17.3 Clinipace Phase I - IV Clinical Development Services Major Product Offerings
7.17.4 Clinipace Phase I - IV Clinical Development Services Revenue in Global Market (2018-2023)
7.17.5 Clinipace Key News & Latest Developments
7.18 OCT Clinical
7.18.1 OCT Clinical Company Summary
7.18.2 OCT Clinical Business Overview
7.18.3 OCT Clinical Phase I - IV Clinical Development Services Major Product Offerings
7.18.4 OCT Clinical Phase I - IV Clinical Development Services Revenue in Global Market (2018-2023)
7.18.5 OCT Clinical Key News & Latest Developments
7.19 EPS Group
7.19.1 EPS Group Company Summary
7.19.2 EPS Group Business Overview
7.19.3 EPS Group Phase I - IV Clinical Development Services Major Product Offerings
7.19.4 EPS Group Phase I - IV Clinical Development Services Revenue in Global Market (2018-2023)
7.19.5 EPS Group Key News & Latest Developments
7.20 Beijing Sun-novo Pharmaceutical Research
7.20.1 Beijing Sun-novo Pharmaceutical Research Company Summary
7.20.2 Beijing Sun-novo Pharmaceutical Research Business Overview
7.20.3 Beijing Sun-novo Pharmaceutical Research Phase I - IV Clinical Development Services Major Product Offerings
7.20.4 Beijing Sun-novo Pharmaceutical Research Phase I - IV Clinical Development Services Revenue in Global Market (2018-2023)
7.20.5 Beijing Sun-novo Pharmaceutical Research Key News & Latest Developments
7.21 Dmedglobal
7.21.1 Dmedglobal Company Summary
7.21.2 Dmedglobal Business Overview
7.21.3 Dmedglobal Phase I - IV Clinical Development Services Major Product Offerings
7.21.4 Dmedglobal Phase I - IV Clinical Development Services Revenue in Global Market (2018-2023)
7.21.5 Dmedglobal Key News & Latest Developments
7.22 WuXi AppTec
7.22.1 WuXi AppTec Company Summary
7.22.2 WuXi AppTec Business Overview
7.22.3 WuXi AppTec Phase I - IV Clinical Development Services Major Product Offerings
7.22.4 WuXi AppTec Phase I - IV Clinical Development Services Revenue in Global Market (2018-2023)
7.22.5 WuXi AppTec Key News & Latest Developments
7.23 Elixir Clinical Research
7.23.1 Elixir Clinical Research Company Summary
7.23.2 Elixir Clinical Research Business Overview
7.23.3 Elixir Clinical Research Phase I - IV Clinical Development Services Major Product Offerings
7.23.4 Elixir Clinical Research Phase I - IV Clinical Development Services Revenue in Global Market (2018-2023)
7.23.5 Elixir Clinical Research Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Phase I - IV Clinical Development Services Market Opportunities & Trends in Global Market
Table 2. Phase I - IV Clinical Development Services Market Drivers in Global Market
Table 3. Phase I - IV Clinical Development Services Market Restraints in Global Market
Table 4. Key Players of Phase I - IV Clinical Development Services in Global Market
Table 5. Top Phase I - IV Clinical Development Services Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Phase I - IV Clinical Development Services Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Phase I - IV Clinical Development Services Revenue Share by Companies, 2018-2023
Table 8. Global Companies Phase I - IV Clinical Development Services Product Type
Table 9. List of Global Tier 1 Phase I - IV Clinical Development Services Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Phase I - IV Clinical Development Services Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Phase I - IV Clinical Development Services Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Phase I - IV Clinical Development Services Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Phase I - IV Clinical Development Services Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Phase I - IV Clinical Development Services Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Phase I - IV Clinical Development Services Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Phase I - IV Clinical Development Services Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2024-2029
Table 30. Syneos Health Company Summary
Table 31. Syneos Health Phase I - IV Clinical Development Services Product Offerings
Table 32. Syneos Health Phase I - IV Clinical Development Services Revenue (US$, Mn) & (2018-2023)
Table 33. Syneos Health Key News & Latest Developments
Table 34. PPD Company Summary
Table 35. PPD Phase I - IV Clinical Development Services Product Offerings
Table 36. PPD Phase I - IV Clinical Development Services Revenue (US$, Mn) & (2018-2023)
Table 37. PPD Key News & Latest Developments
Table 38. GVI CDS Company Summary
Table 39. GVI CDS Phase I - IV Clinical Development Services Product Offerings
Table 40. GVI CDS Phase I - IV Clinical Development Services Revenue (US$, Mn) & (2018-2023)
Table 41. GVI CDS Key News & Latest Developments
Table 42. Parexel Company Summary
Table 43. Parexel Phase I - IV Clinical Development Services Product Offerings
Table 44. Parexel Phase I - IV Clinical Development Services Revenue (US$, Mn) & (2018-2023)
Table 45. Parexel Key News & Latest Developments
Table 46. Clinical Leader Company Summary
Table 47. Clinical Leader Phase I - IV Clinical Development Services Product Offerings
Table 48. Clinical Leader Phase I - IV Clinical Development Services Revenue (US$, Mn) & (2018-2023)
Table 49. Clinical Leader Key News & Latest Developments
Table 50. Thermo Fisher Scientific Company Summary
Table 51. Thermo Fisher Scientific Phase I - IV Clinical Development Services Product Offerings
Table 52. Thermo Fisher Scientific Phase I - IV Clinical Development Services Revenue (US$, Mn) & (2018-2023)
Table 53. Thermo Fisher Scientific Key News & Latest Developments
Table 54. LabCorp Company Summary
Table 55. LabCorp Phase I - IV Clinical Development Services Product Offerings
Table 56. LabCorp Phase I - IV Clinical Development Services Revenue (US$, Mn) & (2018-2023)
Table 57. LabCorp Key News & Latest Developments
Table 58. Worldwide Clinical Trial Company Summary
Table 59. Worldwide Clinical Trial Phase I - IV Clinical Development Services Product Offerings
Table 60. Worldwide Clinical Trial Phase I - IV Clinical Development Services Revenue (US$, Mn) & (2018-2023)
Table 61. Worldwide Clinical Trial Key News & Latest Developments
Table 62. CROS NT Company Summary
Table 63. CROS NT Phase I - IV Clinical Development Services Product Offerings
Table 64. CROS NT Phase I - IV Clinical Development Services Revenue (US$, Mn) & (2018-2023)
Table 65. CROS NT Key News & Latest Developments
Table 66. Dynakin Company Summary
Table 67. Dynakin Phase I - IV Clinical Development Services Product Offerings
Table 68. Dynakin Phase I - IV Clinical Development Services Revenue (US$, Mn) & (2018-2023)
Table 69. Dynakin Key News & Latest Developments
Table 70. Rho, Inc. Company Summary
Table 71. Rho, Inc. Phase I - IV Clinical Development Services Product Offerings
Table 72. Rho, Inc. Phase I - IV Clinical Development Services Revenue (US$, Mn) & (2018-2023)
Table 73. Rho, Inc. Key News & Latest Developments
Table 74. Synteract Company Summary
Table 75. Synteract Phase I - IV Clinical Development Services Product Offerings
Table 76. Synteract Phase I - IV Clinical Development Services Revenue (US$, Mn) & (2018-2023)
Table 77. Synteract Key News & Latest Developments
Table 78. ICBio CRO Company Summary
Table 79. ICBio CRO Phase I - IV Clinical Development Services Product Offerings
Table 80. ICBio CRO Phase I - IV Clinical Development Services Revenue (US$, Mn) & (2018-2023)
Table 81. ICBio CRO Key News & Latest Developments
Table 82. Sofpromed Company Summary
Table 83. Sofpromed Phase I - IV Clinical Development Services Product Offerings
Table 84. Sofpromed Phase I - IV Clinical Development Services Revenue (US$, Mn) & (2018-2023)
Table 85. Sofpromed Key News & Latest Developments
Table 86. Profil Company Summary
Table 87. Profil Phase I - IV Clinical Development Services Product Offerings
Table 88. Profil Phase I - IV Clinical Development Services Revenue (US$, Mn) & (2018-2023)
Table 89. Profil Key News & Latest Developments
Table 90. ICON Plc Company Summary
Table 91. ICON Plc Phase I - IV Clinical Development Services Product Offerings
Table 92. ICON Plc Phase I - IV Clinical Development Services Revenue (US$, Mn) & (2018-2023)
Table 93. ICON Plc Key News & Latest Developments
Table 94. Clinipace Company Summary
Table 95. Clinipace Phase I - IV Clinical Development Services Product Offerings
Table 96. Clinipace Phase I - IV Clinical Development Services Revenue (US$, Mn) & (2018-2023)
Table 97. Clinipace Key News & Latest Developments
Table 98. OCT Clinical Company Summary
Table 99. OCT Clinical Phase I - IV Clinical Development Services Product Offerings
Table 100. OCT Clinical Phase I - IV Clinical Development Services Revenue (US$, Mn) & (2018-2023)
Table 101. OCT Clinical Key News & Latest Developments
Table 102. EPS Group Company Summary
Table 103. EPS Group Phase I - IV Clinical Development Services Product Offerings
Table 104. EPS Group Phase I - IV Clinical Development Services Revenue (US$, Mn) & (2018-2023)
Table 105. EPS Group Key News & Latest Developments
Table 106. Beijing Sun-novo Pharmaceutical Research Company Summary
Table 107. Beijing Sun-novo Pharmaceutical Research Phase I - IV Clinical Development Services Product Offerings
Table 108. Beijing Sun-novo Pharmaceutical Research Phase I - IV Clinical Development Services Revenue (US$, Mn) & (2018-2023)
Table 109. Beijing Sun-novo Pharmaceutical Research Key News & Latest Developments
Table 110. Dmedglobal Company Summary
Table 111. Dmedglobal Phase I - IV Clinical Development Services Product Offerings
Table 112. Dmedglobal Phase I - IV Clinical Development Services Revenue (US$, Mn) & (2018-2023)
Table 113. Dmedglobal Key News & Latest Developments
Table 114. WuXi AppTec Company Summary
Table 115. WuXi AppTec Phase I - IV Clinical Development Services Product Offerings
Table 116. WuXi AppTec Phase I - IV Clinical Development Services Revenue (US$, Mn) & (2018-2023)
Table 117. WuXi AppTec Key News & Latest Developments
Table 118. Elixir Clinical Research Company Summary
Table 119. Elixir Clinical Research Phase I - IV Clinical Development Services Product Offerings
Table 120. Elixir Clinical Research Phase I - IV Clinical Development Services Revenue (US$, Mn) & (2018-2023)
Table 121. Elixir Clinical Research Key News & Latest Developments
List of Figures
Figure 1. Phase I - IV Clinical Development Services Segment by Type in 2022
Figure 2. Phase I - IV Clinical Development Services Segment by Application in 2022
Figure 3. Global Phase I - IV Clinical Development Services Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Phase I - IV Clinical Development Services Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Phase I - IV Clinical Development Services Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Phase I - IV Clinical Development Services Revenue in 2022
Figure 8. By Type - Global Phase I - IV Clinical Development Services Revenue Market Share, 2018-2029
Figure 9. By Application - Global Phase I - IV Clinical Development Services Revenue Market Share, 2018-2029
Figure 10. By Type - Global Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Phase I - IV Clinical Development Services Revenue Market Share, 2018-2029
Figure 12. By Application - Global Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Phase I - IV Clinical Development Services Revenue Market Share, 2018-2029
Figure 14. By Region - Global Phase I - IV Clinical Development Services Revenue Market Share, 2018-2029
Figure 15. By Country - North America Phase I - IV Clinical Development Services Revenue Market Share, 2018-2029
Figure 16. US Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Phase I - IV Clinical Development Services Revenue Market Share, 2018-2029
Figure 20. Germany Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2018-2029
Figure 21. France Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Phase I - IV Clinical Development Services Revenue Market Share, 2018-2029
Figure 28. China Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2018-2029
Figure 32. India Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Phase I - IV Clinical Development Services Revenue Market Share, 2018-2029
Figure 34. Brazil Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Phase I - IV Clinical Development Services Revenue Market Share, 2018-2029
Figure 37. Turkey Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2018-2029
Figure 41. Syneos Health Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. PPD Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. GVI CDS Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Parexel Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Clinical Leader Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Thermo Fisher Scientific Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. LabCorp Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Worldwide Clinical Trial Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. CROS NT Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Dynakin Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Rho, Inc. Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Synteract Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. ICBio CRO Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Sofpromed Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Profil Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. ICON Plc Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Clinipace Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. OCT Clinical Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. EPS Group Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Beijing Sun-novo Pharmaceutical Research Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Dmedglobal Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. WuXi AppTec Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 63. Elixir Clinical Research Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
